Barclays
IMNN icon

Barclays’s Imunon IMNN Stock Holding History

Barclays’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Hold
0
– -$1K – 6270
2015
Q4 		– Hold
0
– – – 5825
2015
Q1 		– Sell
-8
Closed -$45K – 7158
2014
Q4 		$45K Sell
8
-1
-11% -$6.94K ﹤0.01% 5803
2014
Q3 		$48K Sell
9
-8
-47% -$69.7K ﹤0.01% 5911
2014
Q2 		$138K Sell
17
-6
-26% -$53.6K ﹤0.01% 5172
2014
Q1 		$189K Buy
23
+8
+53% +$83.3K ﹤0.01% 4841
2013
Q4 		$122K Buy
15
+9
+150% +$108K ﹤0.01% 5462
2013
Q3 		$80K Hold
6
– – ﹤0.01% 5794
2013
Q2 		$78K Buy
+6
New +$83.5K ﹤0.01% 5993

Other funds holding IMNN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Barclays's IMNN Position: Q4 2021 in Review

Barclays sold out of Imunon (IMNN) in Q4 2021, closing a stake of 132 shares — an estimated $24K sold.

Barclays first reported a position in IMNN in Q2 2013 and held it in 13 quarters. The position peaked at $59K in Q2 2014. 37 funds tracked by Wall St. Rank hold IMNN as of Q4 2021.

  • Barclays reported no remaining Imunon position as of Q4 2021 after selling out during the quarter.
  • Barclays sold 132 Imunon shares in Q4 2021, an estimated $24K.
  • Barclays first reported a position in Imunon in Q2 2013 and held it in 13 quarters.
  • Barclays's Imunon position peaked at $59K in Q2 2014.
  • 37 funds tracked by Wall St. Rank held Imunon as of Q4 2021.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.